APA (7th ed.) Citation

Zhao, R., Ke, M., Lv, J., Liu, S., Liu, Y., Zhang, J., . . . Wang, X. (2024). First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: Dosimetry and initial evaluation in prostate cancer patients. European journal of nuclear medicine and molecular imaging, 51(6), 1753-1762. https://doi.org/10.1007/s00259-024-06596-y

Chicago Style (17th ed.) Citation

Zhao, Ruiyue, et al. "First-in-human Study of PSMA-targeting Agent, [18F]AlF-P16-093: Dosimetry and Initial Evaluation in Prostate Cancer Patients." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 6 (2024): 1753-1762. https://doi.org/10.1007/s00259-024-06596-y.

MLA (9th ed.) Citation

Zhao, Ruiyue, et al. "First-in-human Study of PSMA-targeting Agent, [18F]AlF-P16-093: Dosimetry and Initial Evaluation in Prostate Cancer Patients." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 6, 2024, pp. 1753-1762, https://doi.org/10.1007/s00259-024-06596-y.